These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27182702)

  • 21. Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women.
    Hughes E; Imperial M; Wallender E; Kajubi R; Huang L; Jagannathan P; Zhang N; Kakuru A; Natureeba P; Mwima MW; Muhindo M; Mwebaza N; Clark TD; Opira B; Nakalembe M; Havlir D; Kamya M; Rosenthal PJ; Dorsey G; Aweeka F; Savic RM
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
    Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
    Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10.
    Jagannathan P; Bowen K; Nankya F; McIntyre TI; Auma A; Wamala S; Sikyomu E; Naluwu K; Nalubega M; Boyle MJ; Farrington LA; Bigira V; Kapisi J; Aweeka F; Greenhouse B; Kamya M; Dorsey G; Feeney ME
    J Infect Dis; 2016 Jul; 214(2):329-38. PubMed ID: 27067196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens.
    Kapisi J; Bigira V; Clark T; Kinara S; Mwangwa F; Achan J; Kamya M; Soremekun S; Dorsey G
    Malar J; 2015 Feb; 14():53. PubMed ID: 25652127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
    Tarning J; Zongo I; Somé FA; Rouamba N; Parikh S; Rosenthal PJ; Hanpithakpong W; Jongrak N; Day NP; White NJ; Nosten F; Ouedraogo JB; Lindegardh N
    Clin Pharmacol Ther; 2012 Mar; 91(3):497-505. PubMed ID: 22258469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.
    Darpo B; Ferber G; Siegl P; Laurijssens B; Macintyre F; Toovey S; Duparc S
    Br J Clin Pharmacol; 2015 Oct; 80(4):706-15. PubMed ID: 25966781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women.
    Moore BR; Benjamin JM; Auyeung SO; Salman S; Yadi G; Griffin S; Page-Sharp M; Batty KT; Siba PM; Mueller I; Rogerson SJ; Davis TM
    Br J Clin Pharmacol; 2016 Jul; 82(1):199-212. PubMed ID: 26889763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
    Ashley EA; Stepniewska K; Lindegardh N; Annerberg A; Tarning J; McGready R; Phaiphun L; Singhasivanon P; White NJ; Nosten F
    Eur J Clin Pharmacol; 2010 Jul; 66(7):705-12. PubMed ID: 20300743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis.
    Ali AM; Wallender E; Hughes E; Dorsey G; Savic RM
    CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):656-667. PubMed ID: 36919202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
    Matangila JR; Doua JY; Mitashi P; da Luz RI; Lutumba P; Van Geertruyden JP
    Int J Antimicrob Agents; 2017 Mar; 49(3):339-347. PubMed ID: 28108368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers.
    Hai TN; Hietala SF; Van Huong N; Ashton M
    Acta Trop; 2008 Aug; 107(2):145-9. PubMed ID: 18585670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of malaria-induced alteration of metabolism on piperaquine disposition in Plasmodium yoelii infected mice and predicted in malaria patients.
    Xie Y; Zhang Y; Lin F; Chen X; Xing J
    Int J Antimicrob Agents; 2024 Jul; 64(1):107209. PubMed ID: 38761871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydroartemisinin-Piperaquine Chemoprevention and Malaria Incidence After Severe Flooding: Evaluation of a Pragmatic Intervention in Rural Uganda.
    Boyce RM; Hollingsworth BD; Baguma E; Xu E; Goel V; Brown-Marusiak A; Muhindo R; Reyes R; Ntaro M; Siedner MJ; Staedke SG; Juliano JJ; Mulogo EM
    Clin Infect Dis; 2022 Jul; 74(12):2191-2199. PubMed ID: 34499116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
    Tarning J; Lindegardh N; Lwin KM; Annerberg A; Kiricharoen L; Ashley E; White NJ; Nosten F; Day NP
    Antimicrob Agents Chemother; 2014; 58(4):2052-8. PubMed ID: 24449770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children.
    Ding J; Coldiron ME; Assao B; Guindo O; Blessborn D; Winterberg M; Grais RF; Koscalova A; Langendorf C; Tarning J
    Clin Pharmacol Ther; 2020 May; 107(5):1179-1188. PubMed ID: 31652336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism is not a Major Contributor to the Toxicity of Piperaquine, a Long-acting Antimalarial Agent in Artemisinin-based Combination Therapy.
    Zhang L; Liu Z; Zhang Y; Xie Y; Xing J
    Curr Drug Metab; 2021; 22(10):824-834. PubMed ID: 34602032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations.
    Mwebaza N; Cheah V; Forsman C; Kajubi R; Marzan F; Wallender E; Dorsey G; Rosenthal PJ; Aweeka F; Huang L
    PLoS One; 2020; 15(5):e0233893. PubMed ID: 32470030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency.
    Sidhu J; Rojavin M; Pfister M; Edelman J
    Biol Ther; 2014 Dec; 4(1-2):41-55. PubMed ID: 25118975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.